3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 1/2
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
3
INDUSTRY
1
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Breast Neoplasms
341
Neoplasms
247
Prostatic Neoplasms
196
Colorectal Neoplasms
147
Lung Neoplasms
133
Carcinoma, Non-Small-Cell Lung
113
Leukemia, Myeloid, Acute
108
Pancreatic Neoplasms
99
Multiple Myeloma
90
Precursor Cell Lymphoblastic Leukemia-Lymphoma
77
Brain Neoplasms
74
Glioblastoma
70
Head and Neck Neoplasms
69
Carcinoma, Hepatocellular
67
Squamous Cell Carcinoma of Head and Neck
62
Melanoma
60
Neoplasm Metastasis
56
Uterine Cervical Neoplasms
55
Ovarian Neoplasms
54
Rectal Neoplasms
51
Stomach Neoplasms
49
Hematologic Neoplasms
48
Myelodysplastic Syndromes
45
Carcinoma, Renal Cell
45
Recurrence
43
Motor Activity
43
Glioma
43
Triple Negative Breast Neoplasms
42
Esophageal Neoplasms
40
Lymphoma, Non-Hodgkin
39
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Liver Cirrhosis
×
30 days
×
Clear all
NCT01082419
2026-05-14
NARFI
University Hospital, Bordeaux
Phase NA
Completed
109 enrolled
NCT05786482
2026-05-08
EMPOwer
University of Alberta
Phase NA
Completed
825 enrolled
NCT05692024
2026-05-05
COMMENCER
Massachusetts General Hospital
Phase 1/2
Recruiting
80 enrolled